Vasorelaxant effects of the edible flowers Tagetes erecta L. and its possible mechanism of action
Resumen: Context
Tagetes erecta is widely cultivated for its ornamental flowers and has traditionally been used as a diuretic and antihypertensive. However, its effects on blood pressure have not yet been studied.

Objective
To evaluate the vasorelaxant potential of ethanolic extract of T. erecta from two cultivars of edible flowers, yellow and orange.

Materials and Methods
The pharmacological effects of T. erecta extracts as vasorelaxant agents were evaluated using isolated rat aorta rings in an organ bath and by measuring the pharyngeal pumping rate in the Caenorhabditis elegans model.

Results
The extracts induced relaxation in endothelium-intact aortic rings pre-contracted with different agents. Vasorelaxant effect was attenuated by endothelial removal and by pretreatment with L-NAME or ODQ, but not by indomethacin. Statistically significant effects were observed only at low concentrations. Atropine and H-89 reduced the extract-induced response, whereas okadaic acid had no effect. In a calcium-free medium, the extracts reduced contractions induced by CaCl2 and phenylephrine. Relaxation was significantly attenuated by iberiotoxin, glibenclamide, BaCl2, and 4-aminopyridine, while apamin and TRAM-34 had mild effect. The extracts also significantly decreased the pharyngeal pumping rate in C. elegans.

Discussion and Conclusion
The extracts induced concentration-dependent vasorelaxation though both endothelium-dependent and -independent mechanisms. At low concentrations, relaxation was mediated by nitric oxide, while at higher concentrations it involved inhibition of intracellular Ca2+, opening of K+ channels, and activation of protein kinase A. In C. elegans, the extracts significantly reduced pharyngeal pumping. This study is the first to suggest that T. erecta could be beneficial in treating pathologies associated with endothelial dysfunction, such as hypertension.

Idioma: Inglés
DOI: 10.1080/13880209.2025.2583836
Año: 2025
Publicado en: PHARMACEUTICAL BIOLOGY 63, 1 (2025), 778-799
ISSN: 1388-0209

Financiación: info:eu-repo/grantAgreement/ES/DGA/B44-20D
Financiación: info:eu-repo/grantAgreement/ES/UZ/JIUZ-2018-BIO-09
Financiación: info:eu-repo/grantAgreement/ES/UZ/JIUZ-2021-BIO-08
Tipo y forma: Artículo (Versión definitiva)
Área (Departamento): Área Fisiología (Dpto. Farmac.Fisiol.y Med.L.F.)

Creative Commons Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace. No puede utilizar el material para una finalidad comercial.


Exportado de SIDERAL (2025-11-13-14:57:52)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
Artículos > Artículos por área > Fisiología



 Registro creado el 2025-11-13, última modificación el 2025-11-13


Versión publicada:
 PDF
Valore este documento:

Rate this document:
1
2
3
 
(Sin ninguna reseña)